Cuộc đua thuốc giảm cân tại Mỹ | VTV24
TL;DR
The US faces a severe obesity crisis, fueling a booming market for weight-loss drugs like Wegovy, but high costs limit access for many.
Key insights
The growing obesity epidemic in the US is driving a massive market for weight-loss drugs.
- 8 out of 10 adults in the US are overweight or obese.
- The market for weight-loss drugs is projected to reach $100 billion by 2030.
- Companies like Novo Nordisk and Eli Lilly are leading the development of new weight-loss medications.
New weight-loss drugs, like Wegovy and tirzepatide, are showing significant results.
- These drugs mimic hormones that regulate appetite, leading to reduced food intake.
- Clinical trials have shown an average weight loss of 15-20% in participants.
- The drugs are administered via weekly injections.
The high cost of these drugs presents a significant barrier to access.
- Wegovy can cost around $1,450 per month without insurance.
- Many insurance plans do not cover weight-loss medications.
- This leads to a situation where only those who can afford it can access these treatments.
The demand for weight-loss drugs is creating a competitive market and driving innovation.
- Pharmaceutical companies are investing heavily in research and development.
- The focus is on creating more effective and safer weight-loss solutions.
- The market is expected to continue growing as more people seek solutions for obesity.
Key moments
- 00:02Weight loss is a difficult problem for many people.
- 00:34The weight loss market in the US is huge, costing the healthcare system billions annually.
- 01:37The US is facing an obesity epidemic, with 8 out of 10 adults being overweight or obese.
- 02:40The US Department of Agriculture and the Department of Health and Human Services have released new dietary guidelines.
- 03:55The cost of treating obesity in the US is staggering, with direct medical costs alone estimated at $173 billion in 2022.
- 04:21Novo Nordisk and Eli Lilly are leading the race in developing new weight-loss drugs.
- 04:49The demand for weight-loss drugs is high, but the cost is a major barrier for many.
- 05:34New oral weight-loss drugs are in development and are expected to be more affordable.